Related Experiment Video
Updated: Nov 15, 2025

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
Novel Regulators of the IGF System in Cancer
Caterina Mancarella1, Andrea Morrione2, Katia Scotlandi1
1IRCCS Istituto Ortopedico Rizzoli, Laboratory of Experimental Oncology, 40136 Bologna, Italy.
Abstract:
The insulin-like growth factor (IGF) system is a dynamic network of proteins, which includes cognate ligands, membrane receptors, ligand binding proteins and functional downstream effectors. It plays a critical role in regulating several important physiological processes including cell growth, metabolism and differentiation. Importantly, alterations in expression levels or activation of components of the IGF network are implicated in many pathological conditions including diabetes, obesity and cancer initiation and progression. In this review we will initially cover some general aspects of IGF action and regulation in cancer and then focus in particular on the role of transcriptional regulators and novel interacting proteins, which functionally contribute in fine tuning IGF1R signaling in several cancer models. A deeper understanding of the biological relevance of this network of IGF1R modulators might provide novel therapeutic opportunities to block this system in neoplasia.
Insights
The insulin-like growth factor (IGF) system regulates cell growth and metabolism. Dysregulation of IGF signaling is linked to cancer, and understanding its modulators may offer new therapeutic strategies.
Area of Science:
- Molecular Biology
- Endocrinology
- Cancer Biology
Background:
- The insulin-like growth factor (IGF) system is crucial for cell growth, metabolism, and differentiation.
- Aberrations in the IGF network are associated with diseases like diabetes, obesity, and cancer.
Purpose of the Study:
- To review the role of the IGF system in cancer.
- To focus on transcriptional regulators and interacting proteins that modulate IGF1R signaling in cancer models.
Main Methods:
- Literature review focusing on IGF system components and their roles in cancer.
- Analysis of transcriptional regulators and novel interacting proteins influencing IGF1R signaling.
Main Results:
- The IGF system's general role in cancer is discussed.
- Specific focus on how transcriptional regulators and interacting proteins fine-tune IGF1R signaling.
Conclusions:
- Understanding IGF1R modulators is key to comprehending IGF signaling in cancer.
- Further insights may reveal novel therapeutic targets for blocking the IGF system in neoplasia.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation
Negative Regulator Molecules
TGF - β Signaling Pathway